Subgroup analysis of Asian patients in the INPULSIS®trials of nintedanib in idiopathic pulmonary fibrosis-Reference-Cited by-同舟云学术

Subgroup analysis of Asian patients in the INPULSIS®trials of nintedanib in idiopathic pulmonary fibrosis

Author:

Taniguchi Hiroyuki¹,Xu Zuojun²,Azuma Arata³,Inoue Yoshikazu⁴,Li Huiping⁵,Fujimoto Tsuyoshi⁶,Bailes Zelie⁷,Schlenker-Herceg Rozsa⁸,Kim Dong S.⁹

Affiliation:

1. Department of Respiratory Medicine and Allergy; Tosei General Hospital; Aichi Japan

2. Peking Union Medical College Hospital; Beijing China

3. Department of Pulmonary Medicine and Oncology, Graduate School of Medicine; Nippon Medical School; Tokyo Japan

4. Clinical Research Center; National Hospital Organization Kinki-Chuo Chest Medical Center; Osaka Japan

5. Shanghai Pulmonary Hospital; Shanghai China

6. Nippon Boehringer Ingelheim Co., Ltd; Tokyo Japan

7. Boehringer Ingelheim Ltd.; Bracknell UK

8. Boehringer Ingelheim Pharmaceuticals Inc.; Ridgefield Connecticut USA

9. Asan Medical Center; University of Ulsan; Seoul South Korea

Funder

Boehringer Ingelheim

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine

Link

Reference18 articles.

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献